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ABSTRACT 
 
 
Spontaneous tendon ruptures in patients with end-stage renal disease (ESRD) have been reported 
rarely. We describe the largest own group of patients with spontaneous rupture of major tendons.  
Rupture of 16 tendons occurred in 9 patients. Mean patient age was 52.78 years; 77.7 % were 
male. Four patients were treated with hemodialysis, four received renal transplant and one was 
treated with automated peritoneal dialysis. Bilateral rupture was found in 5 patients (3 
quadriceps, one Achilles and one supraspinatus and subscapularis tendon rupture). Distal brachial 
biceps tendon rupture, Achilles tendon rupture, unilateral quadriceps, and rupture of the oblique 
internal abdominal muscle tendon were developed by one patient each. Patients were treated with 
renal replacement therapy for 3 to 21 years (mean 12.89). Five patients were treated with steroids 
and 6 patients received quinolone antibiotic before the tendon rupture. All patients had laboratory 
and clinical signs of hyperparathyroidism. A patient who was treated with APD for 3 years had 
primary hyperparathyroidism with nephrolithiasis as the cause of ESRD.  
Our results demonstrated that patients with hyperparathyroidism are at increased risk for 
development of spontaneous tendon ruptures, and the risk is further amplified when they receive 
quinolone antibiotics and/or steroids.  
 
Key words: tendon rupture, end-stage renal disease, dialysis, renal transplantation, 
hyperparathyroidism, fluoroquinolones, steroids 
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INTRODUCTION 
 
Spontaneous tendon rupture is a rare complication which severely disables patient's activity. It 
generally occurs in association with different chronic metabolic disorders such as diabetes 
mellitus, systemic lupus erythematosus, rheumatoid arthritis, chronic renal failure, gout and 
obesity (1). Especially rare are simultaneous, spontaneous, bilateral ruptures which mostly occur 
in the weight bearing tendons (the quadriceps femoris, Achilles and patellar tendon) (2). Only a 
few cases of spontaneous bilateral tendon ruptures have been reported in the literature to date (3-
13). Tendon ruptures may be attributed to degenerative changes in tendons or changes at their 
attachments to the bone. However, the pathogenesis of spontaneous tendon rupture in uremic 
patients is a matter of controversy. Some authors advocate duration of dialysis with subsequent 
malnutrition, insufficient dialysis and β2-amiloidosis as the main etiologic factor (14), while 
other considered accumulation of uremic toxins as the causative factor of tendon weakness and 
spontaneous ruptures (15). Secondary hyperparathyroidism has been suggested as the main 
reason for tendon ruptures in patients on chronic hemodialysis (16-18). Other factors that may 
predispose to tendon injury in CRF patients include corticosteroid treatment and floroquinolone 
antibiotics (19,20). 
In the present study we evaluated clinical characteristics of 9 patients with the end-stage renal 
disease treated with different renal replacement therapies (RRT) that developed spontaneous 
tendon ruptures. 
 
 
PATIENTS AND METHODS 
 
All patients treated at Department of dialysis University Hospital Zagreb or University Hospital 
Rijeka who required RRT and developed spontaneous tendon rupture were eligible for 
investigation. Investigation was approved by the Ethic committee of the School of medicine, 
University of Zagreb. 
Age, gender, body mass index, primary renal disease, duration of renal disease, history of 
diabetes, hepatitis B and C status, duration and kind of renal replacement treatment, mechanism 
of injury, method of treatment and tendon that ruptured were recorded. Laboratory parameters 
included calcium, phosphorus, alkaline phosphatase, iPTH, albumin, and C-reactive protein.  
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Body mass index was calculated as body weight (kg) / hight (m)2. 
Immunosuppressive protocol in renal transplant recipients included daclizumab 2 mg/kg in 2 
doses (day 0 and day 14 after transplantation), cyclosporine A (trough levels 150-200 µg/L 
during the first several months), mycophenolate mofetil and steroids. Doses of steroids and use of 
fluoroquinolone antibiotics were recorded.  
 
RESULTS 
 
From June 2006 to October 2008, 16 spontaneous tendon ruptures occurred in 9 patients. There 
were 7 male and two female patients. Ruptures occurred after normal activity in all patients. The 
main symptom of tendon rupture was pain accompanied with function impairment. Diagnosis 
was obtained based on clinical and ultrasound examination. 
Clinical characteristics are presented in Table 1. 
 
Table 1. 
 
Age of the patients ranged from 43 to 69 (mean 52.78 years). Most of them required renal 
replacement treatment for long time. Average time on RRT was 12.89 years (range 3-21). Four 
patients were treated with hemodialysis, four patients received a renal allograft from deceased 
donor, and one patient was treated with automated peritoneal dialysis combined with one 
hemodialysis session per week. The most common tendon that ruptured was quadriceps femoris 
tendon, followed by Achilles tendon. We describe for the first time spontaneous ruptures of 
supraspinatus and supscapularis tendons, rupture of obliquus abdominis internus tendon and 
tendon of the short head of the biceps brachii tendon in patients with ESRD.  
Body mass index ranged from 17 to 32 (mean 24.01) kg/m2. Two patients were hepatitis B 
positive, and 4 patients had chronic HCV infection. Patient 7 was treated with pegylated 
interferon prior to transplantation, and had negative HCV RNA at the time of transplantation. 
Four transplanted patients received steroids as part of their immunosuppressive protocol. None of 
them experienced acute rejection which would require increased doses of steroids. Steroids were 
also used in patient 5. Six patients were treated with ciprofloxacine prior to development of 
spontaneous tendon rupture. Two patients received simvastatin for treatment of dyslipidemia. All 
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patients had hyperparathyroidism, and one of them had primary form of the disease which caused 
end-stage renal disease because of kidney stones formation. Laboratory data are presented in 
Table 2.  
 
Table 2. 
 
CaxP product ranged from 2.59 to 7.61 (mean 4.58) mmol2/L2, iPTH from 58.8 to 281.4 (mean 
201.9) pg/mL, and alkaline phosphatase from 40 to 471 IU (mean 148.3). Signs of malnutrition 
were present in 2 patients and obesity in one patient. C-reactive protein was elevated in four 
patients, probably as the consequence of the urinary tract infections that were treated with 
ciprofloxacine. Serum albumin was within the normal range in 7 patients, while 2 patients had 
low albumin levels. 
The dominant arm was affected by the distal biceps tendon rupture in patient 1. Patient 2 
developed avulsion of obliquus abdominis internus tendon insertion to the pelvis after the episode 
of allergic cough. She was treated surgically with reattachment of tendon and improved 
completely. Patient 5 had a history of long-term renal disease. After treatment with hemodialysis 
and renal transplantation with graftectomy due to renal vein thrombosis, she started with 
peritoneal dialysis. After 3 years on peritoneal dialysis she developed severe encapsulating 
sclerosing peritonitis with malnutrition. She was switched back to hemodialysis and started 
treatment with tamoxifen and steroids. Tamoxifen was discontinued after 2 years because of the 
liver toxicity, and she remained on steroids. In June 2008 she developed spontaneous rupture of 
right supraspinatus and subscapularis muscle, and 4 months later rupture of the same tendons on 
the opposite side. She could not ingest phosphate binders due to severe bowel problems. We 
believe that tamoxifen did not add to increase the risk for development of tendon rupture. This 
case is interesting while it raises the awareness of multiple complications in patients with 
sclerosing peritonitis who could not ingest phosphate binders. Patient 9 was relatively short on 
dialysis compared to the rest of the group. However, he had primary hyperparathyroidism and 
had developed ESRD due to nephrolithiasis. He was treated with automated peritoneal dialysis 
and one hemodialysis session per week according to his own wish. None of the patients had 
diffuse calcifylaxis.   
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Tendon ruptures were treated surgically with tendon reinsertion. Unfortunately, tendon biopsies 
were not performed during the surgical procedure. It is possible that some of the patients had 
calcifying tendonitis. The main problem after surgical treatment was impaired wound healing in 
all renal transplant recipients. One of them needed prolonged drainage and antibiotic treatment 
after operation. Patients also experienced delayed recovery and needed prolonged physical 
therapy. Treatment resulted in significant improvement in all patients.  
 
DISCUSSION 
 
The advent of dialysis and renal transplantation has resulted in improved survival of patients with 
chronic renal failure and subsequent development of numerous disease complications. 
Spontaneous tendon ruptures are rare, but potentially serious complications in this group of 
patients. However, the causal relation between chronic renal failure and spontaneous tendon 
rupture is not well understood. We collected the largest own series of patients with spontaneous 
tendon rupture.  Patients were treated with different renal replacement therapies: one patient with 
automated peritoneal dialysis, four patients with hemodialysis, and four received a renal 
transplant.  
Ruptures seen in patients with CRF occur at younger age than in patients with other etiologies 
(2). Average age of patients from our series was 52.78 years what is in concordance with 
previous reports. It was suggested that the uremic environment could predispose development of 
tendon ruptures. Chronic acidosis with the consequent degenerative changes (21,22), 
hyperparathyroidism with weakness of bone-tendon junction (23) and amiloidosis (10,14) may all 
contribute to development of spontaneous tendon ruptures in patients with chronic renal failure. 
Additionally, many of the patients described in previous reports had been treated with 
corticosteroids or fluoroquinolone antibiotics (24-28). Most of the reports proved relationship 
between the length of time on dialysis and occurrence of spontaneous tendon ruptures (12,13,23). 
Our results demonstrate that although most of the patients received renal replacement therapy for 
more than 10 years, spontaneous tendon rupture may occur in patients who were relatively short 
on dialysis, as was the case with patient 9.   
Statins are widely prescribed for treatment of dyslipidemia in renal transplant recipiens. Besides 
the relatively common and well-known side effects as are rhabdomyolysis or mild liver lesion, 
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statins may rarely cause tendonitis or even tendon rupture (29). Their contribution to tendon 
rupture in uraemic patients remains unclear. Two of our patients received statins, one of them 
was treated with hemodialysis and one was transplanted.  
Corticosteroids were found to be associated with tendinopathies more than 40 years ago, with 
majority of cases consisted of tendon ruptures, predominantly of the Achilles tendon (24). All our 
renal transplant recipients received steroids, but none of the patients who developed spontaneous 
tendon rupture was exposed to the boluses of steroids for treatment of acute rejection. Besides the 
renal transplant recipients, steroids could be an important additive factor for tendon injury in 
patient 5. 
Two thirds of our patients who developed spontaneous tendon rupture had chronic hepatitis C 
infection. It is unclear weather hepatitis C infection increase the risk for spontaneous tendon 
rupture, or is merely coincident finding associated with long-term renal disease and treatment 
with blood transfusions before the introduction of erythropoietin for treatment of renal anemia. 
Microscopic tendon lesions occurred with reovirus infection, and resulted in tenosynovitis with 
progressive tendon fibrosis in ckicken (30).  Case reports demonstrated association of hepatitis C 
infection with necrotizing (31) and vacuolar myopathy (32). However, there is no data about the 
possible involvement of hepatitis C virus in tendon injuries. 
High incidence of spontaneous tendon ruptures in renal transplant recipients occurred after 
joining of Croatia to Eurotransplant, an international organization for organ allocation. Previous 
allocation system that was primarily based on HLA matching was changed to an allocation 
scheme with emphasis on the length of dialysis. This resulted in high number of renal 
transplantations performed in the long-term dialysis patients with significant comorbidities. Most 
of these patients had evidence of poorly controlled secondary hyperparathyroidism with high 
levels of iPTH and alkaline phosphatase. Additive effect of high-dose steroids and use of 
ciprofloxacin for treatment of urinary tract infections resulted in spontaneous ruptures with 
prolonged hospitalization and mobility limitations. 
Hyperparathyroidism was common to all patients in the primary, secondary or tertiary form as 
demonstrated in the Table 2. CaxP product ranged from 2.59 to 7.61 mmol2/L2 (mean 4.58), 
iPTH from 58.8 to 281.4 (mean 201.9) pg/mL, and alkaline phosphatase from 40 to 471 IU (mean 
148.3). Renal transplant recipients had low CaxP product due to phosphorus wasting during the 
immediate posttransplant allograft recovery and to the “hungry” bones. The importance of 
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hyperparathyroidism in development of spontaneous tendon injury is clear from the case of 
patient 9 who had tendon rupture only 3 years after he started with dialysis, but had primary 
hyperparathyroidism.  
Treatment results were good. Patients needed prolonged physical therapy after surgical treatment. 
Significant problems with wound healing occurred in renal transplant recipients who received 
immunosuppressive therapy.  
In conclusion, our results demonstrated that patients with hyperparathyroidism are at increased 
risk for development of spontaneous tendon ruptures, and the risk is further amplified when they 
receive fluoroquinolone antibiotics and/or steroids. Hyperparathyroidism should be treated before 
renal transplantation. Fluoroquinolone antibiotics should be avoided in patients with 
hyperparathyroidism, especially at early stages after transplantation when they receive high doses 
of steroids. These patients may be candidates for steroid-free immunosuppressive protocols. 
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Table 1. Clinical parameters of patients with spontaneous tendon ruptures. Gend – gender (f - 
female, m - male), PRD – primary renal disease (DM II – diabetes mellitus type II, GN – chronic 
glomerulonephritis without biopsy, MPGN – mesangioproliferatuve glomerulonephritis), RRT 
(yrs) – time on renal replacement therapy, last RRT –treatment modality at the time of tendon 
rupture, BMI – body mass index, HBV – hepatitis B status, HCV – hepatitis C status, FQ – recent 
history of fluoroquinolone antibiotic treatment, HD – haemodialysis, APD – automated 
peritoneal dialysis, Tx – renal transplantation. 
 
 
Patient Age Gend PRD RRT 
(yrs) 
Last 
RRT 
Tendon BMI HBV HCV Ster Stat FQ 
1 69 m DM II 13 HD m. biceps 
brachii 
28.05 + - - - - 
2 53 f GN chr 12 HD m. obliquus abd. 
internus 
22.86 - + - - + 
3 52 m GN chr 7 HD m. quadriceps 
bil 
32.45 - - - + + 
4 44 m Hypoplasia 21 Tx m. quadriceps 
bil.  
28.36 - + + -  
5 54 f Pyeloneph. 15 HD m. supraspinatus 
and m. 
subscapularis bil 
17.06 + - + - + 
6 62 m GN chr 7 Tx Achils tendon 
bil 
26 - - + - + 
7 43 m MPGN 18 Tx Achiles tendon 28.4 - + + - + 
8 55 m GN chr 20 Tx m. quadriceps 26.5 - + + + - 
9 43 m Primary 
hyperpara 
3 APD 
+ HD 
m. quadriceps 
bil 
26.43 - - - - - 
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Table 2. Laboratory parameters of patients with spontaneous tendon ruptures. Normal ranges are 
indicated in parentheses. CaxP – calcium x phosphorus product, iPTH – intact parathyroid 
hormone, AlP – alkaline phosphatase 
 
 
Patient Ca x P 
(mmol2/L2) 
iPTH (pg/mL) 
(20-120) 
AlP (IU/L) 
(54-119) 
1 3.91 281.4 40 
2 6.48 258.3 43 
3 7.61 127.3 471 
4 2.59 135 128 
5 3.94 378.9 143 
6 5.97 234.6 114 
7 3.56 172.2 105 
8 2.74 58.8 127 
9 4.47 170.6 164 
 
